Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

The Binding Site Group

US

Last updated May 24, 2026

Part of The Binding Site Group Ltd

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (283)

Page 5 of 6
DeviceModel / ReferenceRegistriesClassStatus
Freelite® Human Lambda Free Kit for use on the Beckman AU® series LK018.AU
FDA UDI
Class IIActive
MININEPH Sample Diluent Pack ZK502.R
FDA UDI
N/AUnknown
Human Transferrin BINDARID™ Radial Immunodiffusion Kit RN070.3
FDA UDI
Class IIUnknown
Hu IgG Subclass Liquid Reagent Kits for use on Hitachi 911/912/917 and Modular P LK001.H
FDA UDI
Class IIActive
Optilite IgA CSF Kit LK010.L.OPT.A
FDA UDI
Class IIActive
MININEPH™ Human C3 Kit ZK023.R
FDA UDI
N/AUnknown
MININEPH Human IgG1 Kit ZK006.R
FDA UDI
N/AUnknown
Optilite® Transferrin Control Pack NQ070.OPT
FDA UDI
Class IActive
Optilite Hevylite® IgM Kappa Kit NK625.OPT.A
FDA UDI
Class IIActive
Human IgA1 Subclass BNII Kit NK087.1T
FDA UDI
Class IIActive
Human IgG1 Subclass Liquid Reagent Kit for use on the Beckman IMMAGE®/IMMAGE®800 NK006.IM
FDA UDI
Class IIUnknown
Human Caeruloplasmin NL BINDARID™ Radial Immunodiffusion Kit RN045.3
FDA UDI
Class IIActive
Freelite® Human Lambda Free Kit for use on the Roche Cobas Integra® - Bulk kit LK018.10RI
FDA UDI
Class IIActive
Human Albumin Kit for use on SPAPLUS NK032.S
FDA UDI
N/AUnknown
Human IgG Subclass Control Pack for use on the SPAPLUS® NQ006.S
FDA UDI
Class IUnknown
Optilite® IgG Kit (x10) NK004.10.OPT.A
FDA UDI
Class IIActive
Freelite® Human Kappa Free Kit for use on the Siemens BN™II - Bulk Kit LK016.10T
EUDAMEDFDA UDI
Class IIActive
Freelite® Human Kappa Free Kit for use on the HITACHI 911/912/917/Modular P LK016.H
FDA UDI
Class IIActive
Human IgA2 Kit for use on SPAPLUS LK088.S
FDA UDI
Class IIUnknown
MININEPHPLUS On Board Buffer (4 Bottles) SN107.4
FDA UDI
N/AActive
Optilite Hevylite IgG Kappa Kit NK621.OPT.A
FDA UDI
Class IIActive
Human IgG4 Kit for SPAPLUS (U.S Only) LK009.S.A
FDA UDI
Class IIUnknown
Optilite® Haptoglobin Control Pack NQ058.OPT
FDA UDI
Class IActive
Optilite IgG3 LK008.OPT.A
FDA UDI
Class IIActive
Freelite® Human Kappa Free Kit for use on the Roche Cobas Integra® LK016.RI
FDA UDI
Class IIUnknown
Human IgM kit for use on SPAPLUS NK012.S
FDA UDI
Class IIUnknown
Freelite® Human Kappa Free Kit for use on the Roche Cobas Integra® - Bulk kit LK016.10RI
FDA UDI
Class IIActive
Optilite Caeruloplasmin Kit NK045.OPT.A
FDA UDI
Class IIActive
Anti-Human Total Kappa - Particle - ASR pack MA015
FDA UDI
Class IActive
Human Complement C3 ‘NL’ BINDARID™ Radial Immunodiffusion Kit RN023.3
FDA UDI
Class IIActive
Beckman Immage IgG3 Latex Kit LK008.IM
FDA UDI
Class IIUnknown
Anti-Human IgM - Particle - ASR pack MA012
FDA UDI
Class IActive
Optilite C-Reactive Protein Calibrator NC044.OPT.A
FDA UDI
Class IIActive
Freelite® Human Lambda Free Kit for use on the SPAPLUS – Bulk Kit LK018.10S
FDA UDI
Class IIActive
Optilite Freelite Lambda Free Bulk Kit LK018.10.OPT.A
FDA UDI
Class IIActive
Optilite C3c Kit NK023.OPT.A
FDA UDI
Class IIActive
Human IgG4 Subclass BNII Kit NK009.T
FDA UDI
Class IIUnknown
Freelite® Human Lambda Free Control Pack For use on the Beckman Coulter IMMAGE™ NQ018.IM
FDA UDI
N/AActive
MININEPH™ Human Anti-Streptolysin O Kit ZK189.L.R
FDA UDI
N/AUnknown
Hevylite® Human IgG Kappa Kit for use on the Siemens BN™II NK621.T
FDA UDI
N/AActive
Human Anti Streptolysin-O kit for use on SPAPLUS LK189.S
FDA UDI
Class IUnknown
Human IgA Control Pack for use on the SPAPLUS® NQ010.S
FDA UDI
Class IUnknown
Optilite IgA1 Kit NK087.OPT.A
FDA UDI
Class IIActive
Optilite Hevylite IgG Lambda Kit NK622.OPT.A
FDA UDI
Class IIActive
Optilite IgG Kit NK004.OPT.A
FDA UDI
Class IIActive
Optilite Transferrin Kit NK070.OPT.A
FDA UDI
Class IIActive
Total Haemolytic Complement RC001.1
FDA UDI
Class IIActive
Optilite IgG2 Kit NK007.OPT.A
FDA UDI
Class IIActive
Human CH50 Reagent pack for use on the SPAPLUS NK095.S
FDA UDI
Class IIUnknown
Freelite® Kappa AMR Check Fluid SD BP538.SD
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (28)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Oct 15, 2021Z-0274-2022—terminated

Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer.

May 20, 2021Z-2030-2021—terminated

The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.

Nov 18, 2020Z-0943-2021—terminated

Due to customer complaints of positive bias impacting quality control. The high and low level controls are demonstrating a positive bias compared to assigned values.

Apr 9, 2020Z-2071-2020—terminated

A software issue that may affect the analyzer's result accuracy.

Nov 6, 2019Z-1500-2020—terminated

It has been identified that the rheumatoid factor (RF) calibrator values over recover in comparison to the reference material RF serum. This could result in reporting falsely abnormal results which may lead to unnecessary additional serological testing.

Oct 7, 2019Z-2110-2020—terminated

Assigned Rheumatoid Factor (RF) calibrator value for calibrator component included in kit used to aid in the diagnosis of rheumatoid arthritis over recovers by 7% in comparison to the reference material RF serum. This could result in reporting abnormal (false positive) results, which may lead to unnecessary additional serological testing and a delay in treatment.

Jul 29, 2019Z-1327-2020—terminated

There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

Apr 25, 2019Z-1619-2020—terminated

A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected

Feb 19, 2019Z-0671-2020—terminated

Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits

Nov 6, 2018Z-0604-2019—terminated

Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.

Aug 12, 2018Z-1469-2020—terminated

A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.

Jul 25, 2018Z-0477-2019—terminated

After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.

Mar 9, 2018Z-1301-2018—terminated

The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.

Jan 4, 2018Z-0553-2018—terminated

The low and high controls for the product are returning results above the assigned values.

Aug 23, 2017Z-0002-2018—terminated

The high control for the kit is recovering low and may be out of range for assigned values.

Dec 23, 2016Z-1089-2017—terminated

A change to the lower end of the measuring range and product insert did not reflect the change.The measuring range provided in instrument parameters is correct but contradicts the information provided in the product insert

Oct 28, 2016Z-1053-2017—terminated

A change in the calibration curve causing an increase in false prozone flags.

Jul 5, 2016Z-1043-2017—terminated

Batch numbers listed are reporting Lambda Free Light Chain results >114mg/L that are on average 33% lower than other Optilite Lambda Freelite batches. Therefore users moving to this batch will see results >114mg/L giving lower results and conversely when switching to the next batch results will be seen to shift upwards.

May 13, 2015Z-1018-2017—terminated

Potential risk of the Optilite lid/cover falling suddenly and causing injury when not placed in the fully open position.

Sep 11, 2014Z-1068-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1071-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1073-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1072-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1067-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1070-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1069-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Nov 28, 2012Z-1050-2017—terminated

Calibration curve activity has increased over time in the kit lots listed.

Oct 9, 2012Z-1055-2017—terminated

If a control ring is marked after reading, the software will not flag results that are out of the specified QC range.